| CONDENSED FINANCIAL INFORMATION OF THE PARENT COMPANY (Unaudited) |
NOTE
11 — CONDENSED FINANCIAL INFORMATION OF THE PARENT COMPANY (Unaudited)
The Company performed
a test on the restricted net assets of its consolidated subsidiaries in accordance with Rule 4-08(e)(3) of Regulation S-X promulgated
by the SEC, “General Notes to Financial Statements” and concluded that it was applicable and the Company is required to disclose
the required financial statement information for the parent company.
The subsidiaries did
not pay any dividends to the parent during the periods presented. For the purpose of presenting parent only financial information, the
Company records its investment in its subsidiaries under the equity method of accounting. Such investments are presented on the separate
parent only balance sheets as “investment in subsidiaries” and the income (loss) of the subsidiaries is presented as “share
of income (loss) of subsidiaries.” Certain information and footnote disclosures generally included in financial statements prepared
in accordance with U.S. GAAP have been condensed or are not required.
PARENT COMPANY BALANCE
SHEET
| Schedule of balances sheet | |
| | | |
| | |
| | |
January 31, | | |
July 31, | |
| | |
2026 | | |
2025 | |
| | |
| | |
| |
| ASSETS | |
| | | |
| | |
| Cash | |
$ | 294,584 | | |
$ | 2,177,414 | |
| Prepaid expense | |
| 117,699 | | |
| 39,373 | |
| Receivable from subsidiaries | |
| 1,847,584 | | |
| 497,584 | |
| Investment in subsidiaries | |
| 2,192,177 | | |
| 288,614 | |
| Total Assets | |
$ | 2,604,460 | | |
$ | 3,002,985 | |
| | |
| | | |
| | |
| LIABILITIES | |
| | | |
| | |
| Accounts payable and other accrued liabilities | |
$ | 150 | | |
$ | 18,679 | |
| Due to related parties | |
| – | | |
| – | |
| Total liabilities | |
| 150 | | |
| 18,679 | |
| | |
| | | |
| | |
| Stockholders’ equity | |
| | | |
| | |
| Series A Preferred stock, $0.0001 par value; 80,000 shares authorized; no shares issued and outstanding as of January 31, 2026 and July 31, 2025 | |
| – | | |
| – | |
| Series B Preferred stock, $0.0001 par value; 80,000 shares authorized; 0 and 80,000 shares issued and outstanding as of January 31, 2026 and July 31, 2025, respectively | |
| – | | |
| 8 | |
| Undesignated preferred stock, $0.0001 par value; 19,920,000 shares authorized; no shares issued and outstanding | |
| – | | |
| – | |
| Common stock, $0.0001 par value, 100,000,000 shares authorized; 25,331,803 and 16,531,803 shares issued and outstanding as of January 31, 2026 and July 31, 2025, respectively | |
| 2,533 | | |
| 1,653 | |
| Additional paid-in capital | |
| 6,132,633 | | |
| 5,845,505 | |
| Accumulated deficit | |
| (3,530,856 | ) | |
| (2,862,860 | ) |
| Total stockholders’ equity | |
| 2,604,310 | | |
| 2,984,306 | |
| | |
| | | |
| | |
| Total Liabilities and Stockholders’ Equity | |
$ | 2,604,460 | | |
$ | 3,002,985 | |
PARENT COMPANY STATEMENT OF OPERATIONS
| Schedule of statement of operations | |
| | |
| |
| | |
For the six months ended January 31, | |
| | |
2026 | | |
2025 | |
| | |
| | |
| |
| EXPENSE: | |
| | |
| |
| General and administrative | |
$ | (501,565 | ) | |
$ | (265,185 | ) |
| Selling and marketing | |
| (4,410 | ) | |
| – | |
| | |
| | | |
| | |
| OTHER INCOME | |
| | | |
| | |
| (Loss) gain from investment in subsidiaries | |
| (162,021 | ) | |
| 31,387 | |
| Other income (expense) net | |
| – | | |
| 27,391 | |
| Total other (expense) income | |
| (162,021 | ) | |
| 58,778 | |
| | |
| | | |
| | |
| Net (loss) | |
$ | (667,996 | ) | |
$ | (206,407 | ) |
PARENT COMPANY STATEMENT OF CASH FLOWS
| Schedule of statement of cash flow | |
| | |
| |
| | |
For the six months ended January 31, | |
| | |
2026 | | |
2025 | |
| | |
| | |
| |
| Cash flows from operating activities: | |
| | |
| |
| Net (loss) | |
$ | (667,996 | ) | |
$ | (206,407 | ) |
| Adjustments to reconcile net income to net cash used in operating activities: | |
| | | |
| | |
| Share of (gain) from investment in subsidiaries | |
| 162,021 | | |
| (31,387 | ) |
| Change in operating assets and liabilities: | |
| | | |
| | |
| Prepaid expense and other assets | |
| (8,326 | ) | |
| (3,625 | ) |
| Accounts payable and other accrued liabilities | |
| (18,529 | ) | |
| 112,799 | |
| Net cash (used in) operating activities | |
| (532,830 | ) | |
| (128,620 | ) |
| | |
| | | |
| | |
| Cash flows from financing activities: | |
| | | |
| | |
| Operating proceeds from subsidiaries | |
| – | | |
| 200,000 | |
| Repayment of working capital advance to subsidiary | |
| (1,350,000 | ) | |
| – | |
| Deferred offering costs incurred | |
| – | | |
| (74,125 | ) |
| Net cash (used in) provided by financing activities | |
| (1,350,000 | ) | |
| 125,875 | |
| | |
| | | |
| | |
| Net (decrease) in cash and cash equivalents | |
| (1,882,830 | ) | |
| (2,745 | ) |
| Cash and cash equivalents at beginning | |
| 2,177,414 | | |
| 14,621 | |
| Cash and cash equivalents at ending | |
$ | 294,584 | | |
$ | 11,876 | |
|